New Boxed Warning on severe liver injury with propylthiouracil
2010-05-05
The United States Food and Drug Administration (FDA) the American counterpart to the Saudi Food and Drug Authority (SFDA) has added a Boxed Warning to the label for propylthiouracil, a drug used to treat hyperthyroidism (overactive thyroid), to include information about reports of severe liver injury and acute liver failure, some of which have been fatal, in adult and pediatric patients using this medication.